advanced pharmacology renal agents - npcourses.com handout samples/advanced... · advanced...
TRANSCRIPT
1
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Advanced PharmacologyRenal Agents
Thomas W. Barkley, Jr., PhD, ACNP‐BC, FAANPPresident, Barkley & Associates
www.NPcourses.comand
Professor of NursingDirector of Nurse Practitioner ProgramsCalifornia State University, Los Angeles
Robert Fellin, PharmD, BCPSFaculty, Barkley & Associates
Pharmacist, Cedars‐Sinai Medical CenterLos Angeles, CA
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
The Kidneys Kidneys: primary organs for regulating fluid balance, electrolyte composition and acid-base
balance
Secrete renin, which helps regulate BP
Release erythropoietin, a hormone that stimulates RBC production
Produce calcitriol, the active form of vitamin D, which helps maintain bone homeostasis
Each kidney contains ~ 1 million nephrons
Blood is filtered through the glomerulus
Water and other small molecules readily pass through the glomerulus and enter Bowman’s capsule (the first section of the nephron) and then the proximal tubule
Once in the nephron, the fluid is called filtrate
After leaving the proximal tubule, the filtrate passes through the Loop of Henle and subsequently, the distal tubule
Nephrons empty their infiltrate into collecting ducts and then, into larger structures in the kidney
Fluid leaving the collecting ducts and entering subsequent parts of the kidney is called urine
2
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Anatomy of the Nephron
http://www.as.miami.edu/chemistry/2086/chap26/chapter%2026-new_part1.htm
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Renal Reabsorption, Secretion and Failure As filtrate passes through the nephron, its composition changes
Some substances cross the walls of the nephron to reenter the blood (tubular reabsorption)
GFR: The best marker for estimating kidney function; volume of water filtered through Bowman’s capsule per minute
Excellent compensatory mechanisms with nephrons, so > 50% damage results in a fall in GFR to less than one-half its normal value
More than ½ of all patients with chronic renal failure occur in patients with long standing HTN or diabetes
Kidneys are the primary route of elimination of most drugs or their metabolites
3
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Functions of the Nephron: Summary
http://www.as.miami.edu/chemistry/2086/chap26/chapter%2026-new_part1.htm
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Management of Renal Disease Pharmacologic:
Volume overloadSodium and water hemostasis
Electrolyte disturbancesPotassium and magnesium homeostasis
Mineral and bone disordersCalcium and phosphorous hemostasis
Acid-Base imbalances Anemia Dose adjust/remove/avoid nephrotoxic agents Manage comorbid conditionsHTN, hyperlipidemia, DM
Nonpharmacologic: Renal replacement therapy: (HD, PD, CVVHD) Transplant
4
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Diuretics: Mechanisms of ActionMost commonly, block Na+ reabsorption in the nephron, thus sending
more Na+ to the urine
Chloride ions follow Na+
Because H2O also travels with Na+, blocking the reabsorption of Na+ will increase the volume of urination/diuresis
May affect the renal excretion of other ions, including Mg, K, phosphate, Ca and HCO3
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Carbonic Anhydrase InhibitorsAgents: Acetazolamide (Diamox), methazolamide (Neptazane)
Site of action: Proximal convoluted tubule; blunt sodium bicarbonate reabsorption
Adverse Effects:
Hyperchloremic metabolic acidosis, renal stones, hypokalemia, drowsiness, paresthesias
Comments: Rarely used as diureticsOther applications: glaucoma, urinary alkalinization, metabolic alkalosis, acute mountain sicknessContraindication: hyperammonemia, hepatic encephalopathy
5
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Loop DiureticsAgents: Bumetanide (Bumex), ethacrynic acid (Edecrin),
furosemide (Lasix), torsemide (Demadex)
Site of action: Block sodium absorption at the ascending Loop of Henle
Adverse Effects:
Electrolyte disturbances, dehydration, thirst, dry mouth, weight loss, headache, hypotension, hyperuricemia, hypercalcemia, ototoxicity (rare)
Comments: Most effective diuretics
May induce urine output even when blood flow to the kidneys is diminished
Overuse: hypokalemic metabolic alkalosis
Sulfa allergy (anaphylaxis): use ethacrynic acid
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Thiazide/Thiazide-Like DiureticsAgents: Chlorothiazide (Diuril), chlorthalidone (Thalitone),
hydrochlorothiazide (Microzide), indapamide (Lozol), metolazone (Zaroxolyn)
Site of action: Block sodium absorption at the distal tubule
Adverse Effects:
Electrolyte disturbances, dehydration, thirst, dry mouth, weight loss, headache, hyperglycemia, ototoxicity (rare)
Comments: Primary use: HTNLess efficacious than loop diureticsNot effective in severe renal impairmentIn certain situations may combine with loop diuretic to provide synergistic diuresisChlorothiazide: only parenteral thiazide available
6
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Potassium-Sparing DiureticsAgents: Amiloride (Midamor), triamterene (Dyrenium),
eplerenone* (Inspra), spironolactone* (Aldactone)
Site of action: Reduce sodium absorption in the collecting tubules and ducts; aldosterone antagonist
Adverse Effects: Gynecomastia (spironolactone), hyperkalemia
Comments: Least effective diureticsMost commonly used in combination with other diuretics to reduce potassium lossCaution use in renal impairment or pre-existing hyperkalemiaOveruse: hyperchloremic metabolic acidosis
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Osmotic DiureticsAgents: Mannitol (Osmitrol)
Site of action: Proximal tubule and descending limb of Henle's loop
Adverse Effects:
Expansion of extracellular volume, electrolyte disturbances, dehydration, headache, nausea, vomiting
Comments: Other applications: increased ICP, HD (?)
Not an agent of first choice
Rarely used as diuretic
7
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Vasopressin AntagonistsAgents: Conivaptan (Vaprisol), tolvaptan (Samsca)
Site of action: Inhibit the effects of ADH in the collecting tubule
Adverse Effects:
Dry mouth, thirst, hypernatremia, hypotension
Comments: Applications: SIADH, hyponatremia
Conivaptan: available as IV only; max dose: 40 mg; max duration 4 days; do not use in severe renal impairment
Tolvaptan: avoid in severe renal impairment
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Renal Agents: Sites of Action
http://accessmedicine.mhmedical.com.mlprox.csmc.edu/content.aspx?bookid=388§ionid=45764235
8
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Sodium ImbalancesNormal Range: 135-145 mEq/L
Hypo Na:
Hyper Na:
Fluid restriction, 0.9% saline, 3% saline, conivaptan, tolvaptan
diuretics, hydration
Comments: Determine and treat underlying causeAssess osmolalityAssess fluid statusCalculate total Na deficitMaximum rate of correction: 8-12 mEq/24 hoursMonitor Na levels q2h during correctionMany medications implicated as the cause
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Potassium ImbalancesNormal Range: 3.5-5.0 mEq/L
Hypo K:Hyper K:
KCl, Kphosphate, Kacetatesodium polystyrene sulfonate (Kayexalate), HD
Comments: Determine and treat underlying causePrimary concern: life threatening arrhythmiasCheck for ECG changesCheck serum Mg level; replete if necessaryHypomagnesemia can cause refractory hypokalemiaMax rate: 10 mEq/hour**Max Conc: 10 mEq/50 mL**Oral repletion: no more than 40 mEq at onceMonitor potassium level q2-4 hours or after each 80 mEq
9
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Magnesium ImbalancesNormal Range: 1.5-2.5 mEq/L
Hypo Mg:Hyper Mg:
Magnesium sulfate, magnesium oxidediuretics, HD, calcium chloride
Comments: Determine and treat underlying causePrimary concern: life threatening arrhythmiasCheck for ECG changesMax rate: 1 gram (8 mEq)/hour**Max Conc: 1 gram/50-100 mL**Hypomagnesemia can cause refractory hypokalemia
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Calcium ImbalancesNormal Range: 8.5-10.5 mEq/L (iCa: 1.12-1.30 mmol/L)
Hypo Ca:Hyper Ca:
Calcium gluconate, calcium chloride, othershydration, loop diuretics, bisphosphonates
Comments: Regulated by parathyroid hormone, vitamin D, and calcitonin99% of total body Ca found in bones, less than 1% in the serum40-50% of Ca in the blood is bound to albuminMust correct for hypoalbuminemiaFree or ionized Ca level may be more reliableMax rate: 1 gram (4.65 mEq)/hour**Max Conc: 1 gram/50-100 mL**Preferred agent: Ca gluconateCa chloride used for emergent situations
10
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Phosphorus ImbalancesNormal Range: 2.5-4.5 mg/dL
Hypo Phos:Hyper Phos:
Na phosphate, K phosphatehydration, oral phosphate binders, HD
Comments: Majority of Phos found in bonesMax rate: 15 mmol over 5 hours**Max Conc: 15 mmol/100 mL**Infused slowly to reduce/avoid the risk of thrombophlebitis and calcium-phosphate precipitationWatch the salt (Na vs. K) content:30 mmol Phos = 44 mEq K or 40 mEq NaWeight based dosing guidelines available
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Acid-Base Imbalances1. Evaluate the patient
What is occurring physiologically
2. Assess the pH
If the pH < 7.4 = ACIDOSIS
If the pH > 7.4 = ALKALOSIS
3. Assess the pCO2 & Assess the HCO3
pH < 7.35 and HCO3 < 22 metabolic acidosis
pH < 7.35 and pCO2 > 40 respiratory acidosis
pH > 7.45 and pCO2 < 40 respiratory alkalosis
pH > 7.45 and HCO3 > 28 metabolic alkalosis
11
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Contrast Induced NephropathyNo specific treatment once contrast-induced acute kidney
injury (AKI) developsPatients at increased risk:serum creatinine ≥ 1.5 mg/dL, eGFR < 60/1.73 m2
Management: best treatment of contrast-induced kidney injury is preventionAvoid of repetitive studies that are closely spaced (within 48 to 72
hours)
N-Acetylcysteine (Mucomyst)
Hydration with or without sodium bicarbonate (??)
2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury
Unit 4 ©2014 Barkley & AssociatesUnit 4 ©2014 Barkley & Associates
Assessment of Renal Function Creatinine (estimated GFR)
Intake/output (I/O); urine output
Concurrent diuretic/natriuretic use
Concurrent vasopressor use
Clinical/hemodynamic status
Sepsis, s/p cardiac arrest
Past medical history
CHF
Renal insufficiency vs. chronic kidney disease